FDA Inspection 649158 — New York Blood Center, Inc.

New York Blood Center, Inc. — FEI 2276020

The FDA completed an inspection of New York Blood Center, Inc. on Feb 4, 2010 in New Brunswick, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Feb 4, 2010
Fiscal Year
2010
Product Type
Biologics
Project Area
Blood and Blood Products
Location
New Brunswick, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.